Table 3.
Pathway annotation of predicted miRNA targets
| Signaling and metabolic pathways | p-value a |
|---|---|
| PTEN Signaling | 2.82E-05 |
| Axonal Guidance Signaling | 2.82E-05 |
| ERK/MAPK Signaling | 6.61E-05 |
| Wnt/β-catenin Signaling | 3.09E-04 |
| Cardiac β-adrenergic Signaling | 3.09E-03 |
| Hypoxia Signaling in the Cardiovascular System | 4.79E-03 |
| Ephrin Receptor Signaling | 6.31E-03 |
| Neuregulin Signaling | 1.00E-02 |
| Integrin Signaling | 1.00E-02 |
| PPARα/RXRα Activation | 1.00E-02 |
| PI3K/AKT Signaling | 1.02E-02 |
| PPAR Signaling | 1.20E-02 |
| Inositol Phosphate Metabolism | 1.41E-02 |
| Actin Cytoskeleton Signaling | 1.51E-02 |
| B Cell Receptor Signaling | 1.51E-02 |
| G-Protein Coupled Receptor Signaling | 1.74E-02 |
| Insulin Receptor Signaling | 1.82E-02 |
| Neurotrophin/TRK Signaling | 1.82E-02 |
| IGF-1 Signaling | 2.95E-02 |
| Notch Signaling | 3.72E-02 |
| Tight Junction Signaling | 3.98E-02 |
| Nicotinate and Nicotinamide Metabolism | 4.68E-02 |
| TGF-β Signaling | 4.68E-02 |
a
p-value with B-H Multiple testing correction